A cloned human germ cell tumor-derived cell line differentiating in culture.
We have derived a clonal cell line (HGCT-1) from a lymph node metastasis of a primary testicular germ cell tumor (GCT). The tumor was negative for the embryonal carcinoma (EC) cell marker BerH2 but positive for vimentin, cytokeratin (CK) and desmin. Comparative genomic hybridization (CGH) revealed a high-level amplification at 12p that was observed in both the metastatic tumor and in the cultured HGCT-1 cells. In vitro, the phenotype of HGCT-1 cells was modulated by the culture conditions. In the presence of 10% fetal calf serum (FCS), the majority of HGCT-1 cells lacked CK and desmin. If cultured in 0.5% FCS, HGCT-1 cells acquired a uniform co-expression of vimentin, CK and desmin. Upon treatment with retinoic acid (RA), HGCT-1 cells lost the expression of desmin, but exhibited abundant CK filaments. Simultaneously, they started to express desmoplakin, form desmosomes and flatten on the culture substratum. The RA-induced changes were irreversible, whereas those following the culture in 0.5% FCS were at least partially reversible. When xenografted into an immunosuppressed rat, HGCT-1 cells formed a tumor consisting of epithelial- and mesenchymal-like structures. HGCT-1 cells thus represent a pluripotential cell system with a capacity for reversible phenotypic modulation and for irreversible differentiation into epithelial-type cells. The behavior of this novel cell line, distinct from established EC cell models, suggests a complex regulation of GCT cell differentiation.
Department of Pathology, Haartman Institute, University of Helsinki, Finland.
J
J
Tienari
I
I
Reima
M L
ML
Larramendy
S
S
Knuutila
K
K
von Boguslawsky
M
M
Kaartinen
I
I
Virtanen
E
E
Lehtonen
D000818:Animals; D018929:Cell Culture Techniques / Q000379:methods; D002454:Cell Differentiation / Q000187:drug effects; D002869:Chromosome Aberrations; D002999:Clone Cells; D003893:Desmin / Q000032:analysis; D018237:Germinoma / Q000235:genetics* / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D007165:Immunosuppression Therapy; D007633:Keratins / Q000032:analysis; D008207:Lymphatic Metastasis; D008297:Male; D008648:Mesoderm / Q000166:cytology / Q000187:drug effects; D010641:Phenotype; D051381:Rats; D013736:Testicular Neoplasms / Q000235:genetics* / Q000473:pathology*; D014183:Transplantation, Heterologous; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014746:Vimentin / Q000032:analysis
D003893:Desmin; D014746:Vimentin; D014212:Tretinoin; D007633:Keratins